Cohen David, Zhou Ming
The Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Clin Lab Med. 2005 Jun;25(2):259-77. doi: 10.1016/j.cll.2005.01.003.
RCC represents a group of clinically and genetically diverse diseases. Familial RCC syndromes, although rare, provide an invaluable model to study the molecular mechanisms of renal carcinogenesis. Many causative oncogenes and tumor suppressor genes have been identified and it is now possible to identify the affected individuals and carriers by genetic testing. Understanding of the molecular pathways of these genes will have a significant impact on the diagnosis and treatment of familial and sporadic RCC.
肾细胞癌(RCC)是一组临床和基因特征各异的疾病。家族性RCC综合征虽然罕见,但为研究肾癌发生的分子机制提供了极为宝贵的模型。许多致癌基因和抑癌基因已被确定,现在通过基因检测能够识别受影响的个体和携带者。了解这些基因的分子途径将对家族性和散发性RCC的诊断和治疗产生重大影响。